Literature DB >> 19629221

Diagnosis and treatment of vertigo and dizziness.

Michael Strupp1, Thomas Brandt.   

Abstract

INTRODUCTION: Vertigo is not a separate disease process, but a multisensory and sensorimotor syndrome with various etiologies and pathogeneses. It is among the commonest symptoms presented to doctors, with a lifetime prevalence of around 20% to 30%. Patients have often consulted multiple physicians before a diagnosis is made and therapy initiated.
METHODS: Selective literature research and review of the guidelines of the German Neurological Society.
RESULTS: A careful history remains the cornerstone of diagnosis. Once the correct diagnosis is made, specific and effective treatments are available for most peripheral, central, and psychogenic forms of dizziness. Treatment may include medication, physiotherapy, and psychotherapy; a few limited cases may require surgical treatment. The treatment of choice for acute vestibular neuritis is the administration of corticosteroids. Menière's disease is treated with high-dose, long-term betahistine. A new approach to the management of downbeat and upbeat nystagmus, and of episodic ataxia type 2, involves the use of aminopyridines as potassium-channel blockers. Close multidisciplinary cooperation is essential in dizziness, and further multicenter studies are needed.

Entities:  

Keywords:  Menière’s disease; dizziness; migraine; presenting complaint; vertigo; vestibular disorder

Year:  2008        PMID: 19629221      PMCID: PMC2696792          DOI: 10.3238/arztebl.2008.0173

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  23 in total

1.  Episodic vertigo related to migraine (90 cases): vestibular migraine?

Authors:  M Dieterich; T Brandt
Journal:  J Neurol       Date:  1999-10       Impact factor: 4.849

2.  One-year follow-up of cognitive behavioral therapy for phobic postural vertigo.

Authors:  Johan Holmberg; Mikael Karlberg; Uwe Harlacher; Måns Magnusson
Journal:  J Neurol       Date:  2007-08-03       Impact factor: 4.849

3.  Phobic postural vertigo--a long-term follow-up (5 to 15 years) of 106 patients.

Authors:  D Huppert; M Strupp; N Rettinger; J Hecht; T Brandt
Journal:  J Neurol       Date:  2005-03-04       Impact factor: 4.849

4.  Detection of floccular hypometabolism in downbeat nystagmus by fMRI.

Authors:  R Kalla; A Deutschlander; K Hufner; T Stephan; K Jahn; S Glasauer; T Brandt; M Strupp
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

5.  Downbeat nystagmus: aetiology and comorbidity in 117 patients.

Authors:  J N Wagner; M Glaser; T Brandt; M Strupp
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-09-14       Impact factor: 10.154

Review 6.  Epidemiology of vertigo.

Authors:  Hannelore K Neuhauser
Journal:  Curr Opin Neurol       Date:  2007-02       Impact factor: 5.710

7.  Curing the BPPV with a liberatory maneuver.

Authors:  A Semont; G Freyss; E Vitte
Journal:  Adv Otorhinolaryngol       Date:  1988

8.  Treatment of the gravity dependence of downbeat nystagmus with 3,4-diaminopyridine.

Authors:  A Sprenger; H Rambold; T Sander; S Marti; K Weber; D Straumann; C Helmchen
Journal:  Neurology       Date:  2006-09-12       Impact factor: 9.910

9.  Ménière's disease: a long-term follow-up study of bilateral hearing levels.

Authors:  Masaya Takumida; Akinobu Kakigi; Taizo Takeda; Matti Anniko
Journal:  Acta Otolaryngol       Date:  2006-09       Impact factor: 1.494

10.  Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.

Authors:  M Strupp; O Schüler; S Krafczyk; K Jahn; F Schautzer; U Büttner; T Brandt
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

View more
  37 in total

Review 1.  The treatment and natural course of peripheral and central vertigo.

Authors:  Michael Strupp; Marianne Dieterich; Thomas Brandt
Journal:  Dtsch Arztebl Int       Date:  2013-07-22       Impact factor: 5.594

Review 2.  [Surgical treatment of vestibular vertigo: methods and indications].

Authors:  M Westhofen
Journal:  HNO       Date:  2008-10       Impact factor: 1.284

3.  Switch to Semont maneuver is no better than repetition of Epley maneuver in treating refractory BPPV.

Authors:  Sun-Young Oh; Ji-Soo Kim; Kwang-Dong Choi; Ji-Yun Park; S-H Jeong; Seung-Han Lee; Hak-Seung Lee; Tae-Ho Yang; H-J Kim
Journal:  J Neurol       Date:  2017-07-28       Impact factor: 4.849

4.  Etiologic distribution of dizziness and vertigo in a referral-based dizziness clinic in South Korea.

Authors:  Hyo-Jung Kim; Ja-Ok Lee; Jeong-Yoon Choi; Ji-Soo Kim
Journal:  J Neurol       Date:  2020-04-16       Impact factor: 4.849

Review 5.  Central oculomotor disturbances and nystagmus: a window into the brainstem and cerebellum.

Authors:  Michael Strupp; Katharina Hüfner; Ruth Sandmann; Andreas Zwergal; Marianne Dieterich; Klaus Jahn; Thomas Brandt
Journal:  Dtsch Arztebl Int       Date:  2011-03-25       Impact factor: 5.594

Review 6.  Gait disturbances in old age: classification, diagnosis, and treatment from a neurological perspective.

Authors:  Klaus Jahn; Andreas Zwergal; Roman Schniepp
Journal:  Dtsch Arztebl Int       Date:  2010-04-30       Impact factor: 5.594

7.  Diagnostic indices for vertiginous diseases.

Authors:  Otmar Bayer; Jan-Christian Warninghoff; Andreas Straube
Journal:  BMC Neurol       Date:  2010-10-25       Impact factor: 2.474

8.  Persistent benign paroxysmal positional vertigo: our experience and proposal for an alternative treatment.

Authors:  Marco Alessandrini; Alessandro Micarelli; Isabella Pavone; Andrea Viziano; Domenico Micarelli; Ernesto Bruno
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-02       Impact factor: 2.503

9.  [Diagnosis of vertigo: keep an eye on central eye movement disorders].

Authors:  M Strupp; L E Walther; A Eckhardt-Henn; P Franko Zeitz
Journal:  Ophthalmologe       Date:  2013-01       Impact factor: 1.059

10.  [Diagnosis and treatment options in vertigo syndromes].

Authors:  M Strupp; M Dieterich; A Zwergal; T Brandt
Journal:  Nervenarzt       Date:  2015-10       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.